Latest research, educational guides, and news from the world of institutional investing.
Joseph Mansueto sold roughly $2.0M of Morningstar stock across two February 2026 sessions, extending a long-running founder liquidity pattern after the stock had already repriced lower from late-2025 highs.
Two VIAVI executives sold about $1.7M across late 2025 to early 2026, a period when the company was benefiting from a better demand narrative than it had a year earlier.
Four Travere insiders sold roughly $16.7M across late December through early February, a period when the stock had already been re-rated around the Filspari story.
QuidelOrtho 10% owner Jack Schuler bought more stock in January 2026, extending a buy campaign that had already put several million dollars to work while the company remained in rebuild mode.
Anthony Wood sold roughly $9M of Roku Class A shares across January and February 2026, but the bigger ownership story is that Schedule 13G still showed 12.83% beneficial ownership.
Mitchell Jacobson bought about $17.2 million of MSC Industrial stock in late 2025 after a weak operating stretch, a CFO transition, and a difficult year for the distribution business.
Randal Kirk's September-to-December Precigen selling followed a major corporate milestone: FDA approval of PAPZIMEOS, the company's first approved product in the U.S., and new long-term follow-up messaging around the platform.
Gary Smith's late-December to mid-February Form 4 tape came as Ciena talked about unprecedented AI-related demand, reported $1.43B in fiscal Q1 2026 revenue, and raised full-year guidance.
Alfred P. West Jr.'s 2025 Form 4 tape culminated in a December exercise-and-sale, then SEI announced his planned transition to Chairman Emeritus and later reported strong Q4 results.
Derek Maetzold's November-December Form 4 activity came after Castle Biosciences raised 2025 revenue guidance and the stock surged on the Q3 release, making this a post-strength sell pattern rather than a panic exit.
Mario Gabelli's recent Form 4 tape is a closed-end fund rotation story, not a simple one-stock buy: heavy December purchases in GDV, GAB, GRX, and related vehicles followed by January-February follow-through.
Nike's co-founder has $3.1 billion in reported 'sell value' across his Form 4 filings. But almost every transaction is a gift, conversion, or trust transfer — not a sale. The real story is one of the largest founder-to-philanthropy transfers in American corporate history.
The charitable foundation behind Eli Lilly has filed 10,747 Form 4 transactions since 2003 — all sells. Federal tax law forces the sales. GLP-1 drug revenue has made each share worth more than ever.
Form 4 filings for Jeffrey E. Eberwein show a mixed buy-sell sequence in Star Equity Holdings during December 2025, including a large same-day swap pattern.
Form 4 filings show Ronda E. Stryker sold about $181.7M of Stryker shares on February 4-5, 2026, following the company's latest earnings and guidance cycle.
Form 4 filings show Apple CEO Tim Cook sold roughly $33.4M of AAPL on October 2, 2025, one day after a major exercise-and-tax-withholding cycle.
Form 4 filings show Micron CEO Sanjay Mehrotra sold about $27.5M of MU shares from October 1 to November 7, 2025, after a heavy exercise window and into a record revenue cycle.
Irwin Jacobs co-founded Qualcomm, pioneered CDMA technology that powers every 3G/4G/5G phone on Earth, and filed 5,491 insider transactions — nearly all sells and gifts. His methodical exit from the company he built is a masterclass in founder wealth management.
MicroStrategy's founder filed 2,774 insider transactions over two decades — all sells, zero purchases. His final trade in April 2024 left him with exactly zero personal shares. The company he built now holds half a million Bitcoin worth over $50 billion.
The Rankin family controls 44% of Hyster-Yale and has filed more insider transactions than most Fortune 500 CEO teams combined — across three public companies they built from a coal business.